GF FUND MANAGEMENT CO. LTD. Q4 2025 Filing
Filed January 27, 2026
Portfolio Value
$5.9B
Holdings
643
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (643 positions)
| Stock | Value |
|---|---|
XNCRXencor Inc | $21.0M |
URGNUroGen Pharma Ltd | $21.0M |
UMHUMH Properties Inc | $21.0M |
NVV1Novavax Inc | $21.0M |
SILASila Realty Trust Inc | $21.0M |
VREVeris Residential Inc | $20.0M |
GLUEMonte Rosa Therapeutics Inc | $20.0M |
NTLAIntellia Therapeutics Inc | $20.0M |
ERASErasca Inc | $20.0M |
ABCLAbCellera Biologics Inc | $20.0M |
DAWNDay One Biopharmaceuticals Inc | $18.0M |
I9DNArbutus Biopharma Corp | $18.0M |
ALMSAlumis Inc | $18.0M |
CRMDCorMedix Inc | $18.0M |
CSRCenterspace | $18.0M |
RAPTRAPT Therapeutics Inc | $18.0M |
BCAXBicara Therapeutics Inc | $18.0M |
TBPHTheravance Biopharma Inc | $18.0M |
MESOMesoblast Ltd | $17.0M |
ELVNEnliven Therapeutics Inc | $17.0M |
PDMPiedmont Realty Trust Inc | $17.0M |
KURAKura Oncology Inc | $17.0M |
YUMCYum China Holdings Inc | $17.0M |
JBGSJBG SMITH Properties | $17.0M |
ESPREsperion Therapeutics Inc | $17.0M |
RLJRLJ Lodging Trust | $16.0M |
JANXJanux Therapeutics Inc | $16.0M |
VIRVir Biotechnology Inc | $16.0M |
AVBPArriVent Biopharma Inc | $16.0M |
GONGeron Corp | $16.0M |
KALVKalVista Pharmaceuticals Inc | $16.0M |
GHRSGH Research PLC | $15.0M |
RI2Rigel Pharmaceuticals Inc | $15.0M |
AQSTAquestive Therapeutics Inc | $15.0M |
ORICORIC Pharmaceuticals Inc | $15.0M |
MSAMSA Safety Inc | $15.0M |
ESRTEmpire State Realty Trust Inc | $15.0M |
SMASmartstop Self Storage REIT In | $15.0M |
AATAmerican Assets Trust Inc | $15.0M |
PAHCPhibro Animal Health Corp | $14.0M |
CTMXCytomX Therapeutics Inc | $14.0M |
ARVNArvinas Inc | $14.0M |
LXEOLexeo Therapeutics Inc | $14.0M |
REPLReplimune Group Inc | $14.0M |
GOSSGossamer Bio Inc | $14.0M |
DEAEasterly Government Properties | $14.0M |
ANNXAnnexon Inc | $14.0M |
RGNXREGENXBIO Inc | $14.0M |
AIVApartment Investment and Manag | $13.0M |
PLYMPlymouth Industrial REIT Inc | $13.0M |
PSNLPersonalis Inc | $13.0M |
IVVDInvivyd Inc | $13.0M |
DHCDiversified Healthcare Trust | $13.0M |
ZLABZai Lab Ltd | $13.0M |
FULCFulcrum Therapeutics Inc | $12.0M |
MGTXMeiraGTx Holdings plc | $12.0M |
VTYXVentyx Biosciences Inc | $12.0M |
PRMEPrime Medicine Inc | $12.0M |
LYELLyell Immunopharma Inc | $12.0M |
IONQIonQ Inc | $12.0M |
CMPSCompass Pathways Plc | $12.0M |
CGEMCullinan Therapeutics Inc | $12.0M |
KROSKeros Therapeutics Inc | $12.0M |
PACBPacific Biosciences of Califor | $11.0M |
CRVSCorvus Pharmaceuticals Inc | $11.0M |
WSRWhitestone REIT | $10.0M |
NXRTNexPoint Residential Trust Inc | $10.0M |
PRTAProthena Corp PLC | $10.0M |
NKENIKE Inc | $10.0M |
VNDAVanda Pharmaceuticals Inc | $10.0M |
ABSIAbsci Corp | $10.0M |
IRWDIronwood Pharmaceuticals Inc | $10.0M |
DSGNDesign Therapeutics Inc | $10.0M |
SAFESafehold Inc | $10.0M |
ZVRAZevra Therapeutics Inc | $9.0M |
MRVIMaravai LifeSciences Holdings | $9.0M |
HPPHudson Pacific Properties Inc | $9.0M |
LENZLENZ Therapeutics Inc | $9.0M |
BIOABioAge Labs Inc | $9.0M |
0HQKCBL & Associates Properties In | $9.0M |
DELLDell Technologies Inc | $9.0M |
GLPGGalapagos NV | $9.0M |
FDMT4D Molecular Therapeutics Inc | $8.0M |
NBPNovaBridge Biosciences | $8.0M |
PEPGPepGen Inc | $8.0M |
GOODGladstone Commercial Corp | $8.0M |
AHHArmada Hoffler Properties Inc | $8.0M |
KYTXKyverna Therapeutics Inc | $8.0M |
ETONEton Pharmaceuticals Inc | $8.0M |
SLDBSolid Biosciences Inc | $8.0M |
INNSummit Hotel Properties Inc | $8.0M |
NVTSNavitas Semiconductor Corp | $8.0M |
ALXAlexander's Inc | $8.0M |
EOLSEvolus Inc | $8.0M |
ENTAEnanta Pharmaceuticals Inc | $8.0M |
IMRXImmuneering Corp | $8.0M |
SIGASIGA Technologies Inc | $8.0M |
AUTLAutolus Therapeutics PLC | $7.0M |
TECXTectonic Therapeutic Inc | $7.0M |
KMDAKamada Ltd | $7.0M |